Snapshot from Jun 26, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / United States — Centers for Disease Control and Prevention / Regeneron Pharmaceuticals

United States — Centers for Disease Control and Prevention & Regeneron Pharmaceuticals

1 shared events · Importance 3 · Last updated Jun 03, 2026

Importance
3
Shared Events
1
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
Shared Events (1)
49
Accidents
Unknown Event
United States — Centers for Disease Control and Prevention: The United States — Centers for Disease Control and Prevention>>> declared the Ebola outbreak a Public Health Emergency of Continental Security, emphasizing the urgency of coordinated action and mobilizing resources for response and preparedness.
Regeneron Pharmaceuticals: Regeneron Pharmaceuticals has an antibody treatment, a component of Inmazeb, which was approved for the Ebola virus and is being prioritized for clinical trials against the Bundibugyo ebolavirus.
May 18, 2026 · 505 articles
NEWSDESK
Explore this relationship live

Track how United States — Centers for Disease Control and Prevention and Regeneron Pharmaceuticals interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.